Skip to content

    Inmune Bio (INMB) stock price & financials

    View INMB earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+13.7% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $50.0K
    Operating Profit
    -$12.29M
    -$9.47M
    -$9.90M
    -$24.57M
    -$7.43M
    +39.5%
    -$5.47M
    +42.2%
    -$5.81M
    +41.3%
    -$1.48M
    +94.0%
    Strengthening
    Net Profit
    -$12.09M
    -$9.22M
    -$9.74M
    -$24.46M
    -$6.47M
    +46.5%
    -$5.26M
    +42.9%
    -$5.41M
    +44.5%
    -$1.27M
    +94.8%
    Strengthening
    EPS
    $-0.60
    $-0.43
    $-1.05
    $-0.24
    +60.0%
    $-0.20
    +53.5%
    $-0.05
    +95.2%
    Strengthening
    Other Income
    $193.0K
    $166.0K
    $113.0K
    $961.0K
    +397.9%
    $210.0K
    $405.0K
    +144.0%
    $203.0K
    +79.6%
    Strengthening
    Interest
    $145.0K
    $0
    Depreciation
    Profit before Tax
    MarginsOPM
    -19810.0%
    Tax
    ReturnsROIC
    5.6%
    4.3%
    4.5%
    11.3%
    3.0%
    -46.5%
    2.4%
    -42.9%
    2.5%
    -44.5%
    0.6%
    -94.8%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$186.2K$7.00M$21.97M$74.81M$52.15M$35.85M$20.92M$24.75M$18.41M
    Short-Term Investments
    Total Current Assets$849.3K$7.76M$23.99M$82.61M$64.67M$39.94M$22.66M$29.89M$23.80M
    Net PP&E$191.5K$156.0K$726.0K$507.0K$414.0K$307.0K$1.87M$2.51M
    Goodwill
    Intangibles$16.51M$16.51M$16.51M$16.51M$16.51M$16.51M$16.51M
    Total Assets$17.36M$24.47M$40.66M$99.94M$81.80M$57.00M$39.56M$32.35M$26.84M
    LiabilitiesTotal Current Liabilities$823.8K$700.4K$1.78M$4.36M$10.92M$18.46M$7.22M$8.42M$5.89M
    Short-Term Debt$5.00M$9.92M
    Long-Term Debt$15.00M$9.70M$15.00M
    Long-Term Leases$160.2K$126.0K$284.0K$526.0K$397.0K$244.0K$411.0K$593.0K
    Total Liabilities$823.8K$860.5K$1.90M$19.72M$21.69M$18.86M$7.46M$8.83M$6.48M
    EquityCommon Stock & APIC$8.7K$10.8K$13.0K$18.0K$18.0K$18.0K$22.0K$27.0K$28.0K
    Retained Earnings-$13.60M-$21.28M-$33.38M-$63.72M-$91.01M-$121.02M-$163.10M-$209.04M-$215.72M
    Total Equity$16.54M$23.61M$38.75M$80.22M$60.10M$37.34M$32.10M$23.52M$20.36M
    HighlightsNet Cash / (Debt)$37.46M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$2.06M-$5.38M-$8.94M-$28.50M-$22.69M-$11.98M-$33.36M-$22.58M-$14.96M
    Cash from Investing-$15.00M-$1.04M
    Cash from Financing$900.0K$12.21M$23.89M$96.36M$729.0K-$4.22M$18.21M$27.61M
    SummaryCapital Expenditure-$1.04M
    Free Cash Flow-$23.62M
    FCF Margin-47248.0%

    Ratios